Published in Blood Weekly, September 13th, 2007
Working with scientists at Stanford University, Vermillion intends to develop a blood test for the diagnosis of PAD and the Company's development program is aimed at identifying...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.